SC
FATE icon

Steven Cohen’s Fate Therapeutics FATE Stock Holding History

Steven Cohen’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
442,228
+399,109
+926% +$739K ﹤0.01% 2720
2026
Q1 		$51.7K Sell
43,119
-1,484,867
-97% -$1.81M ﹤0.01% 3658
2025
Q4 		$1.5M Buy
+1,527,986
New +$1.83M ﹤0.01% 2653
2024
Q2 		– Sell
-1,584,300
Closed -$11.6M – 2025
2024
Q1 		$11.6M Sell
1,584,300
-1,904,863
-55% -$11.8M 0.03% 660
2023
Q4 		$13M Buy
3,489,163
+3,415,762
+4,654% +$8.06M 0.03% 597
2023
Q3 		$156K Buy
73,401
+63,265
+624% +$210K ﹤0.01% 1832
2023
Q2 		$48.2K Buy
+10,136
New +$55.9K ﹤0.01% 1613
2020
Q4 		– Sell
-151,564
Closed -$6.06M – 977
2020
Q3 		$6.06M Sell
151,564
-175,272
-54% -$6.12M 0.03% 522
2020
Q2 		$11.2M Buy
+326,836
New +$9.74M 0.07% 306
2020
Q1 		– Sell
-782,783
Closed -$15.3M – 875
2019
Q4 		$15.3M Sell
782,783
-397,306
-34% -$6.31M 0.08% 304
2019
Q3 		$18.3M Buy
1,180,089
+586,589
+99% +$11.2M 0.11% 238
2019
Q2 		$12M Buy
593,500
+93,500
+19% +$1.68M 0.06% 349
2019
Q1 		$8.79M Buy
+500,000
New +$7.89M 0.04% 429

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steven Cohen's FATE Position: Q2 2026 in Review

Steven Cohen increased its Fate Therapeutics (FATE) stake by 926% in Q2 2026, buying an estimated $739K and bringing the position to 442,228 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2720.

Steven Cohen first reported a position in FATE in Q1 2019 and has held it in 13 quarters since. The position peaked at $18.3M in Q3 2019. 155 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Steven Cohen held 442,228 shares of Fate Therapeutics worth $1.19M as of Q2 2026.
  • Steven Cohen bought 399,109 Fate Therapeutics shares in Q2 2026, an estimated $739K.
  • Fate Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2720 holding.
  • Steven Cohen first reported a position in Fate Therapeutics in Q1 2019 and has held it in 13 quarters since.
  • Steven Cohen's Fate Therapeutics position peaked at $18.3M in Q3 2019.
  • 155 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.